Wei Su

Clinical outcomes and their relationship with tigecycline exposure in critically ill patients with drug resistant infections

Background Dosing tigecycline, an important last resort for carbapenem-resistant organisms, should be under the guidance of pharmacokinetic/pharmacodynamic (PK/PD) theory. However, tigecycline has shown large interindividual variability in PK among different patients, and its PK/PD target has limited data support. This...